Patient Activation is the Missing Link in Direct-to-Patient Success

The Gap Between Availability and Adoption

Direct-to-Patient programs are built with strong logistics, digital ordering, and competitive pricing. Yet availability does not equal adoption. Patients don’t automatically shift to a DTP model just because it exists. They must:

• Understand their eligibility and the options available in a DTP model
• Trust the new pathway to therapy
• Engage, while experiencing minimal friction throughout the process

Without these, even a strong DTP offering becomes underutilized infrastructure.

Patient Activation: The Engine Behind DTP

Patient activation converts access into action. Activation is a coordinated journey across three make-or-break moments that determine whether a prescription flows through the DTP channel:

• Education: Educating on the DTP model in a clear, relevant, and trustworthy manner
• Enrollment: Enabling patients to seamlessly opt into the pharmacy pathway
• Eligibility & Access Confirmation: Ensuring patients are verified and can proceed without delay

The Valeris Direct-to-Patient Engagement platform engages patients the moment a therapy decision is made, reducing delays, uncertainty, and administrative burden that often occur between prescribing and therapy initiation.

Education: Reframing How Patients Think About Pharmacy

Direct-to-Patient services disrupt familiar pharmacy models. Patients must understand why DTP is relevant, how it affects cost and convenience, and why it is trustworthy. Clarity and reassurance often delivered through providers are critical.

The Valeris Perspective:

Education in Direct-to-Patient options must be intentional and orchestrated, combining provider enablement, targeted patient communications, and behavioral insights to drive not just awareness, but confidence and action.

Enrollment: The Critical Conversion Point

Once a patient is willing to use a DTP, the experience must match that intent. Enrollment into DTP pathways can involve multiple forms or portals, re-entering known information, unclear next steps, and delays between prescription and fulfillment. Every point of friction increases the likelihood that patients will revert to familiar channels or abandon the process altogether.

The Valeris Perspective:

Enrollment should be embedded into the care journey, not treated as a separate task. The most effective DTP models integrate enrollment at the point of prescribing, supported by digital tools and human assistance that remove friction entirely. Through automated outreach, patients receive personalized guidance that helps them understand insurance coverage, identify affordability options, coordinate pharmacy fulfillment, and access education and support resources related to their therapy. This direct connection empowers patients to take an active role in their treatment journey while simplifying the path to therapy.

Eligibility & Access: Where Momentum Is Won or Lost

Even after a patient enrolls, the DTP experience can stall at eligibility. Patients need clear answers to simple questions regarding eligibility, payment, and medication delivery. When answers are delayed or unclear, confidence erodes quickly. Manual verification processes and disconnected data systems are often the culprit, introducing lag at the exact moment patients expect immediacy.

The Valeris Perspective:

Eligibility should be resolved in real time. Intelligent automation and integrated data ecosystems are essential to delivering the speed, accuracy, and transparency patients now expect. Many patients experience confusion or delays after receiving a prescription, often unsure of the next steps needed to access treatment. By engaging patients directly and guiding them through the access process, Valeris’s DTP platform helps reduce friction in the healthcare experience and ensures patients are connected to the support services designed to help them start and stay on therapy.

From Pharmacy Model to Patient Experience

During the last year, the industry has focused on building the DTP infrastructure: prescription receipt, distribution, dispensing, and pricing, but patients don’t experience infrastructure, they experience journeys.

The transition from prescription to fulfillment must feel clear, immediate, effortless, and trustworthy. This requires more than operational excellence. It requires activation orchestration: connecting education, enrollment, and eligibility into a seamless, continuous experience.

The Valeris Perspective:

The future of DTP lies in unifying these components into a single, patient-centered ecosystem where data, technology, and services work together to guide patients from awareness to therapy without disruption.

Activation Is the Scaling Factor

Organizations that solve for patient activation will unlock higher channel adoption, faster time to therapy, improved adherence, and stronger ROI on DTP channel investments. Those that don’t will continue to see a gap between what their DTP model can do, and what it delivers.

To realize the full promise of DTP, the industry must expand its focus from building access to driving activation, improved patient experience design, and engagement. Direct-to-Patient models don’t succeed when a prescription is written, they succeed when a patient receives medication and their experience is flawless.